Türk Medline
ADR Yönetimi
ADR Yönetimi

CLINICAL SIGNIFICANCE OF CELIAC TRUNCUS VARIATIONS IN GASTRIC CANCER SURGERY: A RETROSPECTIVE COHORT STUDY IN THE TURKISH POPULATION

İbrahim Burak Bahçecioğlu, Müjdat Turan

Anatolian Current Medical Journal - 2025;7(6):906-912

Department of Surgical Oncology, Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkiye

 

Aims: Gastric cancer is the fifth most common malignancy worldwide. Celiac truncus variations are one of the most important factors complicating the surgical process of total gastrectomy and D2 lymph node dissection in the surgical treatment of gastric cancer. This study aimed to evaluate the frequency of celiac truncus variations in patients undergoing gastrectomy for gastric cancer and their impact on clinical outcomes. Methods: Preoperative computed tomography images of 114 patients who underwent total gastrectomy between January 2023 and June 2025 were retrospectively evaluated. Arterial variations were categorized according to the Michels classification. Postoperative liver enzyme levels, lymph node dissection efficacy, and clinical outcomes were analyzed in patients with arterial anatomic variations. Results: Celiac truncus variations were detected in 19.3% of patients (n=22). The most common variation was ALHA (aberran left hepatic artery), at a rate of 9.6%. No statistically significant difference was found between postoperative 24-hour ALT and AST levels in patients with hepatic artery variations and those with normal anatomy. The increase in AST and ALT parameters at the 24th hour postoperatively in 22 patients with hepatic artery variations was not significant compared to the preoperative results (AST=22-26.5, p=0.476 and ALT=18-18.5, p=0.602). There was no significant difference between the groups in terms of lymph node dissection efficacy (22.8+/-7.7 vs 23.3+/-11.6, p=0.985) and oncological outcomes. Conclusion: Celiac artery variations, especially those in the presence of ALHA, can be safely managed with appropriate perioperative assessment and experienced surgical technique. While these variations do not negatively affect oncological surgical outcomes, transient postoperative liver enzyme elevations may occur.